BCM specifically binds to VEGF, as a result, BCM expresses its anti-tumor effects by directly inhibiting tumor angiogenesis, reducing interstitial pressure, and improving the vascular permeability that accompanies the normalization of tumor blood vessels, thereby improving the transfer of combination anticancer drugs to tumors [21, 22]. This evidence concerns the gene VEGFA and neoplasm.